Sch412348 is primarily used in research settings to study its potential therapeutic effects, particularly in the field of oncology. It has shown promise in inhibiting specific pathways involved in cancer cell proliferation, making it a candidate for targeted cancer therapies. Additionally, it is being explored for its role in modulating cellular processes that could be beneficial in treating inflammatory diseases. Researchers are also investigating its pharmacokinetics and safety profile to determine its suitability for clinical applications. Its unique mechanism of action makes it a valuable tool for understanding disease mechanisms and developing novel treatments.